Total Migraine freedom for breath powered intranasal delivery of 22 mg Sumatriptan Powder (Avp-825) Versus 100 mg oral sumatriptan from the compass study of acute treatment of Migraine [PDF]
Rashmi Halker +3 more
openalex +1 more source
Sumatriptan is not the only analgesic used inappropriately
Peter J. Goadsby
openalex +2 more sources
Comparison of the vasoconstrictor effects of the selective 5‐HT1D‐receptor agonist L‐775,606 with the mixed 5‐HT1B/1D‐receptor agonist sumatriptan and 5‐HT in human isolated coronary artery [PDF]
J. Longmore +5 more
openalex +1 more source
Subcutaneous sumatriptans for acute migraine attacks in adults [PDF]
Christopher S. Lim, Manpreet Singh
openalex +1 more source
Changes in systolic time intervals—a non‐invasive marker for the haemodynamic effects of sumatriptan [PDF]
Stuart Hood +4 more
openalex +1 more source
Functional Hybrid Nanoemulsions for Sumatriptan Intranasal Delivery [PDF]
Lígia Nunes de Morais Ribeiro +8 more
openalex +1 more source
Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial [PDF]
Ana Licina +4 more
openalex +1 more source

